Honest Company (HNST) Chief Growth Officer Reports 6,176-Share Sale Under 10b5-1
Rhea-AI Filing Summary
Katherine Barton, the Chief Growth Officer of Honest Company (HNST), reported a sale of 6,176 shares of common stock on 08/11/2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025, and executed at a weighted average price of $3.89 (individual trade prices ranged from $3.785 to $3.95).
After the reported transactions, the reporting person beneficially owns 926,996 shares, held directly. That total expressly includes 622,833 restricted stock units that are payable in an equivalent number of shares of the issuer's common stock.
Positive
- None.
Negative
- None.
Insights
Katherine Barton reported a planned sale under a 10b5-1 plan and retains substantial direct ownership including a large RSU position.
The Form 4 shows a sale of 6,176 shares executed under a Rule 10b5-1 trading plan adopted May 12, 2025, with a reported weighted average sale price of $3.89. The disclosure of the plan date and the price range conforms to standard insider-trading controls and provides investors with timing context. The reporting person continues to hold 926,996 shares directly, which includes 622,833 restricted stock units payable in common shares, preserving meaningful alignment with shareholders.
Insider sale appears procedural under a pre-established plan; reported holdings remain sizable and include a large RSU component.
The transaction is documented as a sale under an affirmative defense 10b5-1 plan and the Form 4 discloses the weighted average sale price and the price range across multiple trades. No derivative transactions were reported. The post-transaction beneficial ownership figure and the note that 622,833 units are RSUs are material facts for modeling potential future share issuance, dilution, and insider alignment, but the filing contains no earnings or operational data.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 6,176 | $3.89 | $24K |
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.785 to $3.95, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Includes 622,833 restricted stock units which are payable in an equivalent number of shares of the Issuer's common stock.